UPDATE 1-Biotech company Relypsa explores potential sale -sources
April 7 (Reuters) - Relypsa Inc, a U.S. developer of treatments for high blood potassium, is exploring a sale following overtures from a number of potential buyers, according to several people...
No comments:
Post a Comment